These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 37398660)

  • 1. Strategies to reinvigorate exhausted CD8
    Guan Q; Han M; Guo Q; Yan F; Wang M; Ning Q; Xi D
    Front Immunol; 2023; 14():1204363. PubMed ID: 37398660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamentals to therapeutics: Epigenetic modulation of CD8
    Blake MK; O'Connell P; Aldhamen YA
    Front Cell Dev Biol; 2022; 10():1082195. PubMed ID: 36684449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
    Cheng H; Ma K; Zhang L; Li G
    Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing T-cell Dysfunction and Exhaustion in Cancer.
    Zarour HM
    Clin Cancer Res; 2016 Apr; 22(8):1856-64. PubMed ID: 27084739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the role of T-cell exhaustion-related genes in colorectal cancer: a single-cell bioinformatics perspective.
    Tu W; Tu Y; Tan C; Zhong H; Xu S; Wang J; Huang L; Cheng L; Li H
    Funct Integr Genomics; 2023 Aug; 23(3):259. PubMed ID: 37528306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer.
    Zhang J; Lei F; Tan H
    Front Immunol; 2023; 14():1166128. PubMed ID: 37275913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.
    Mao J; Li J; Chen J; Wen Q; Cao M; Zhang F; Li B; Zhang Q; Wang Z; Zhang J; Shen J
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade.
    Budimir N; Thomas GD; Dolina JS; Salek-Ardakani S
    Cancer Immunol Res; 2022 Feb; 10(2):146-153. PubMed ID: 34937730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high interferon gamma signature of CD8
    Li S; Li K; Tian F; Li H; Xia Q; Li T; Dong B; Li D; Yu J; Zhang J; Wang L; Zhang C; Xu S; Zhao Y; Liu Y
    Front Immunol; 2022; 13():1056144. PubMed ID: 36685525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.
    Naoi Y; Morinaga T; Nagasaki J; Ariyasu R; Ueda Y; Yamashita K; Zhou W; Kawashima S; Kawase K; Honobe-Tabuchi A; Ohnuma T; Kawamura T; Umeda Y; Kawahara Y; Nakamura Y; Kiniwa Y; Yamasaki O; Fukushima S; Kawazu M; Suzuki Y; Nishikawa H; Hanazawa T; Ando M; Inozume T; Togashi Y
    Cancer Res; 2024 Jul; 84(13):2109-2122. PubMed ID: 38635899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4
    Fu J; Yu A; Xiao X; Tang J; Zu X; Chen W; He B
    Am J Cancer Res; 2020; 10(12):4234-4250. PubMed ID: 33414997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
    Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
    J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic plasticity of T cell fate decision.
    Pan X; Wang J; Zhang L; Li G; Huang B
    Chin Med J (Engl); 2024 Apr; 137(7):762-775. PubMed ID: 38086394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variety of 'exhausted' T cells in the tumor microenvironment.
    Nagasaki J; Togashi Y
    Int Immunol; 2022 Oct; 34(11):563-570. PubMed ID: 35460561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.